Psychedelics and biopharma company
Mydecine (CSE:MYCO) (OTC:MYCOF) recently announced the successful export of 20 kilograms of dried psilocybin mushrooms from a cultivation facility in Jamaica to a facility in Canada.
A World’s First: According to the Denver-based company, this represents the first-ever legal international export of psilocybin mushrooms.
Mydecine was able to receive the shipment by the exercise of a Health Canada Schedule 1 Dealer’s License held by its Canadian facility, which permits the “import/export, research and development, cultivation, product development, and commercial sale of active psychedelic medicinal compounds.”
“We are now able to access a quality source of much needed product for both our own research purposes, as well as provide CGMP naturally-derived psilocybin to sell and transfer to other licensed research facilities around the globe,” Mydecine CEO and Chairman Joshua Bartch said in a prepared statement.